The European Medicines Agency and the Co-ordination Group for Mutual Recognition and Decentralized Procedures (CMDh) have issued a revised guidance that clarifies the information manufacturers should ...
The European Medicines Agency (EMA) has opened a new consultation on a draft guideline that would revise a set of biosimilar guidelines first put in place six years ago. The guideline, On non-clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results